These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30233306)

  • 21. A different vision of translational research in biomarker discovery: a pilot study on circulatory mitochondrial proteins as Parkinson's disease potential biomarkers.
    Anjo SI; Dos Santos PV; Rosado L; Baltazar G; Baldeiras I; Pires D; Gomes A; Januário C; Castelo-Branco M; Grãos M; Manadas B
    Transl Neurodegener; 2020; 9():11. PubMed ID: 32266064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry.
    Zhang X; Yin X; Yu H; Liu X; Yang F; Yao J; Jin H; Yang P
    Analyst; 2012 Jan; 137(2):490-5. PubMed ID: 22108571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.
    Luan H; Liu LF; Tang Z; Zhang M; Chua KK; Song JX; Mok VC; Li M; Cai Z
    Sci Rep; 2015 Sep; 5():13888. PubMed ID: 26365159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA Profiles in Parkinson's Disease Prefrontal Cortex.
    Hoss AG; Labadorf A; Beach TG; Latourelle JC; Myers RH
    Front Aging Neurosci; 2016; 8():36. PubMed ID: 26973511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma Metabolic Disturbances in Parkinson's Disease Patients.
    Gątarek P; Sekulska-Nalewajko J; Bobrowska-Korczaka B; Pawełczyk M; Jastrzębski K; Głąbiński A; Kałużna-Czaplińska J
    Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Metabolomic Approach Reveals the Alteration in Human Serum and Cerebrospinal Fluid Composition in Parkinson's Disease Patients.
    Plewa S; Poplawska-Domaszewicz K; Florczak-Wyspianska J; Klupczynska-Gabryszak A; Sokol B; Miltyk W; Jankowski R; Kozubski W; Kokot ZJ; Matysiak J
    Pharmaceuticals (Basel); 2021 Sep; 14(9):. PubMed ID: 34577635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel biomarkers for Parkinson's disease by metabolomic technologies.
    Hatano T; Saiki S; Okuzumi A; Mohney RP; Hattori N
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):295-301. PubMed ID: 25795009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease.
    Glonnegger H; Beyle A; Cerff B; Gräber S; Csoti I; Berg D; Liepelt-Scarfone I
    J Alzheimers Dis; 2016 Jul; 53(4):1475-84. PubMed ID: 27392856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
    van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP
    J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combination of machine learning and untargeted metabolomics identifies the lipid metabolism -related gene CH25H as a potential biomarker in asthma.
    Ding X; Qin J; Huang F; Feng F; Luo L
    Inflamm Res; 2023 May; 72(5):1099-1119. PubMed ID: 37081162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive serum metabolic and proteomic characterization on cognitive dysfunction in Parkinson's disease.
    Zhang N; Tang C; Ma Q; Wang W; Shi M; Zhou X; Chen F; Ma C; Li X; Chen G; Gao D
    Ann Transl Med; 2021 Apr; 9(7):559. PubMed ID: 33987257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between plasma ceramides and cognitive and neuropsychiatric manifestations in Parkinson's disease dementia.
    Xing Y; Tang Y; Zhao L; Wang Q; Qin W; Ji X; Zhang J; Jia J
    J Neurol Sci; 2016 Nov; 370():82-87. PubMed ID: 27772793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cerebral glucose metabolism in Parkinson's disease with dementia].
    Ma AJ; Zhang BS; Pan XD; Gao S; Li ZG
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2623-8. PubMed ID: 19080710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolomic profiling reveals altered phenylalanine metabolism in Parkinson's disease in an Egyptian cohort.
    Shebl N; El-Jaafary S; Saeed AA; Elkafrawy P; El-Sayed A; Shamma S; Elnemr R; Mekky J; Mohamed LA; Kittaneh O; El-Fawal H; Rizig M; Salama M
    Front Mol Biosci; 2024; 11():1341950. PubMed ID: 38516193
    [No Abstract]   [Full Text] [Related]  

  • 35. PDD-5S: A useful screening tool for Parkinson's disease dementia.
    Lee WJ; Wu SL; Li JY; Chen CC; Lin JJ; Peng GS; Lin TK; Wang SJ; Chen RS; Yang YH; Tsai CH; Hsu JL; Liao YC; Chen SP; Fuh JL
    Parkinsonism Relat Disord; 2016 Apr; 25():85-90. PubMed ID: 26872691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolomics-based identification of metabolic alterations in PARK2.
    Okuzumi A; Hatano T; Ueno SI; Ogawa T; Saiki S; Mori A; Koinuma T; Oji Y; Ishikawa KI; Fujimaki M; Sato S; Ramamoorthy S; Mohney RP; Hattori N
    Ann Clin Transl Neurol; 2019 Mar; 6(3):525-536. PubMed ID: 30911576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease.
    Luan H; Liu LF; Meng N; Tang Z; Chua KK; Chen LL; Song JX; Mok VC; Xie LX; Li M; Cai Z
    J Proteome Res; 2015 Jan; 14(1):467-78. PubMed ID: 25271123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated analysis of proteomics and metabolomics reveals the potential sex determination mechanism in Odontobutis potamophila.
    Wang T; Zhu W; Zhang H; Wen X; Yin S; Jia Y
    J Proteomics; 2019 Sep; 208():103482. PubMed ID: 31401171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.